Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
DellaCamera Capital Management, LLC
DellaCamera Provides Update on Court Developments Relating to Its Consent Solicitation to Remove CEO of Enzon
May 30th, 2009
DellaCamera Capital Management, LLC (“DellaCamera”) and related entities, which beneficially hold approximately 8.3% of the shares of Enzon Pharmaceuticals, Inc. (“Enzon” or the “Company”) (NASDAQ: ENZN), today disclosed that the Delaware Court of Chancery has denied Enzon’s motion to expedite proceedings in a lawsuit Enzon filed against DellaCamera relating to its consent solicitation to remove CEO and President Jeffrey H. Buchalter. DellaCamera stipulated, and the Court ordered, that the stockholder proposals, if adopted by the stockholders, shall not be implemented or have any effect upon Jeffrey H. Buchalter’s employment agreement until the Court of Chancery has an...
Source: Law & Health Weekly (2009-05-30)
|
